Kwoh, T. Jesse External Entity


Sort by

Selected publications

  • Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.  Clinical cancer research : an official journal of the American Association for Cancer Research2001 Academic Article GET IT
    Times cited: 122